Apotea AB (publ)
STO:APOTEA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Apotea AB (publ)
STO:APOTEA
|
SE |
|
B
|
Bank Handlowy w Warszawie SA
WSE:BHW
|
PL |
|
S
|
Selvita SA
WSE:SLV
|
PL |
|
Societe Generale SA
PAR:GLE
|
FR |
|
Keysight Technologies Inc
NYSE:KEYS
|
US |
|
H
|
Husqvarna AB
XBER:HRZ
|
SE |
|
Applied DNA Sciences Inc
NASDAQ:APDN
|
US |
|
Alsea SAB de CV
BMV:ALSEA
|
MX |
|
B
|
BYD Co Ltd
DUS:BY6A
|
CN |
|
A
|
Anglo American PLC
XBER:NGLB
|
UK |
|
S
|
Swedbank AB
SWB:FRYA
|
SE |
|
G
|
Gdex Bhd
KLSE:GDEX
|
MY |
|
Kaizen Discovery Inc
XTSX:KZD
|
CA |
Wall St Price Targets
APOTEA Price Targets Summary
Apotea AB (publ)
According to Wall Street analysts, the average 1-year price target for APOTEA is 85.68 SEK with a low forecast of 68.68 SEK and a high forecast of 105 SEK.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is APOTEA's stock price target?
Price Target
85.68
SEK
According to Wall Street analysts, the average 1-year price target for APOTEA is 85.68 SEK with a low forecast of 68.68 SEK and a high forecast of 105 SEK.
What is the Revenue forecast for Apotea AB (publ)?
Projected CAGR
12%
Over the last 3 years, the compound annual growth rate for Revenue has been 14%. The projected CAGR for the next 3 years is 12%.
What is the Gross Profit forecast for Apotea AB (publ)?
Projected CAGR
42%
Over the last 3 years, the compound annual growth rate for Gross Profit has been 21%. The projected CAGR for the next 3 years is 42%.
What is the Operating Income forecast for Apotea AB (publ)?
Projected CAGR
22%
Over the last 3 years, the compound annual growth rate for Operating Income has been 83%. The projected CAGR for the next 3 years is 22%.
What is the Pre-Tax Income forecast for Apotea AB (publ)?
Projected CAGR
23%
Over the last 3 years, the compound annual growth rate for Pre-Tax Income has been 111%. The projected CAGR for the next 3 years is 23%.
What is the Net Income forecast for Apotea AB (publ)?
Projected CAGR
23%
Over the last 3 years, the compound annual growth rate for Net Income has been 126%. The projected CAGR for the next 3 years is 23%.
